A Medical Device Daily

Trevi Health Ventures and Peter Hinchliffe reported the formation of Interventional & Surgical Innovations (ISI; New York), a company that will develop early-stage medical device technologies with an initial focus on cardiovascular products.

ISI said it will work to transition early-stage technologies into viable products. Trevi will provide funding through the proof-of-concept stage, with the goal of spinning out products in which it will have significant equity stakes and continue ongoing funding, it said. It said it will analyze the markets, acquire intellectual property and know-how, complete prototype development, implement clinical programs and launch commercialization.

Hinchliffe, a medical device entrepreneur with expertise in interventional, cardiac and vascular surgery, will manage ISI. Previously, Hinchliffe held senior management positions at the Interventional and Intervascular divisions of Datascope (Montvale, New Jersey) and prior to that at the U.S. Surgical division of Tyco Healthcare (Mansfield, Massachusetts).

ISI also reported a relationship with Professor Frans Moll, as clinical advisor, to aid in the development of a suite of surgical and interventional technologies through licenses for a number of products under development. Moll is a vascular surgeon based at Utrecht University (the Netherlands), involved in several technology introductions over the years, the company said.

Trevi Health invests in growth-stage companies in medical devices, biopharmaceuticals and healthcare services.